[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339302-105":59,"doc-detail-339302-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cystatin-sa-attenuates-gastric-cancer-cells-growth-and-increases-sensitivity-to-oxaliplatin-via-pi3kakt-signaling-pathway","Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway","","Cystatin SA (CST2) is a cysteine protease inhibitor whose dysregulation has been reported across multiple cancers, yet its mechanisms in gastric cancer remain insufficiently defined. This study examines CST2 expression and function in gastric cancer, combining Western blot validation with lentiviral CST2 overexpression in GC cell models. Functional assays evaluate proliferation, migration, invasion, cell cycle, and apoptosis, while PI3K/AKT pathway activity is assessed alongside oxaliplatin chemosensitivity. Results indicate CST2 is reduced in tissues and cell lines and enhances oxaliplatin responsiveness via PI3K/AKT signaling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cystatin-sa-attenuates-gastric-cancer-cells-growth-and-increases-sensitivity-to-oxaliplatin-via-pi3kakt-signaling-pathway/339302/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cystatin-sa-attenuates-gastric-cancer-cells-growth-and-increases-sensitivity-to-oxaliplatin-via-pi3kakt-signaling-pathway/339302.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this study on CST2 in gastric cancer?","Question",{"text":112,"@type":113},"To investigate CST2 expression and determine its molecular functions in gastric cancer, including effects on tumor behavior and drug response.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CST2 expression and its role in gastric cancer cell function assessed?",{"text":117,"@type":113},"CST2 expression was analyzed and validated by Western blot, then CST2 was overexpressed in GC cells using lentivirus, followed by assays for proliferation, colony formation, migration/invasion, cell cycle, and apoptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links CST2 to oxaliplatin sensitivity?",{"text":121,"@type":113},"CST2 improves chemosensitivity to oxaliplatin through the PI3K/AKT signaling pathway in gastric cancer cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339302,1790169332,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Journal of Cancer Research and Clinical Oncology (2024) 150:244  \n[https://doi.org/10.1007/s00432-024-05780-9](https://doi.org/10.1007/s00432-024-05780-9)  \nCystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway  \nYida Lu1 · Huizhen Wang1 · Sihan Chen2 · Bo Yang1 · Yaxian Li1 · Yongxiang Li1  \nReceived: 3 March 2024 / Accepted: 3 May 2024 / Published online: 8 May 2024 © The Author(s) 2024  \nAbstract  \nPurpose Cystatin SA (CST2) belongs to the superfamily of cysteine protease inhibitors. Emerging research indicates that CST2 is often dysregulated across various cancers. Its role and molecular mechanisms in gastric cancer remain underexplored. This study aims to explore the expression and function of CST2 in gastric cancer.  \nMethods CST2 expression was analyzed and validated through Western blot. CST2 overexpression was induced by lentivirus in GC cells, and the correlation between CST2 expression levels and downstream signaling pathways was assessed. In addition, multiple assays, including cell proliferation, colony formation, wound-healing, and transwell migration/invasion, were considered to ascertain the influence of CST2 overexpression on gastric cancer. The cell cycle and apoptosis were detected by flow cytometry.  \nResults CST2 expression at the protein level was decreased to be reduced in both gastric cancer tissues and cell lines, and CST2 expression attenuate gastric cancer growth, an effect restricted to gastric cancer cells and absent in gastric epithelial GES-1 cells. Furthermore, CST2 was demonstrated to improve chemosensitivity to Oxaliplatin in gastric cancer cells through the PI3K/AKT signaling pathway.  \nConclusion These findings indicate that CST2 is downregulated at the protein level in gastric cancer tissues and cell lines. Additionally, CST2 was found to attenuate the growth of gastric cancer cells and to enhance sensitivity to Oxaliplatin through the PI3K/AKT signaling pathway, specific to gastric cancer cell lines. CST2 may serve as a tumor suppressor gene increasing sensitivity to Oxaliplatin in gastric cancer.  \nKeywords CST2 · Gastric cancer · Oxaliplatin · PI3K/AKT  \nAbbreviations  \nCST2 Cystatin SA  \nGC Gastric cancer  \nWB Western blot  \nCCK-8 Cell counting Kit-8  \nYida Lu and Huizhen Wang contributed equally to this work.  \n* Yongxiang Li[liyongxiangamu@163.com](liyongxiangamu@163.com)  \n1 Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, People’s Republic of China  \n2 Taikang Ningbo Hospital, Ningbo, Zhejiang 315000, People’s Republic of China  \nIntroduction  \nGastric cancer (GC) is one of the most aggressive and lethal malignancies of the digestive system, with a higher incidence in males than in females (Sung et al. 2021) . The main risk factors include Helicobacter pylori infection, unhealthy diets, high alcohol consumption, and smoking (Campbell et al. 2007 ; Ishaq and Nunn 2015 ; Kim et al. 2014) . The majority of GC cases are classified as adenocarcinomas, accounting for 80–90%(Casamayor et al. 2018) . The WHO classifies GC into multiple subtypes, including papillary, tubular, mucinous, poorly cohesive carcinoma (signet-ring cell carcinoma and other variants), and mixed adenocarcinoma. The Lauren classification system consists of intesti  \nnal, diffuse, and indeterminate types (Bray et al. 2018) .  \nCurrently, treatment regimens against GC can be created from a molecular perspective, as many signaling pathways are abnormally regulated in GC cases (Clementset al. 2002 ; Feng et al. 2010) . Although surgical resection  \nis widely accepted as the main treatment for GC, chemotherapy remains a vital alternative, especially when resection is not feasible or the cancer is in metastatic stages. However, acquired resistance to chemotherapy agents limits their clinical efficacy in GC treatment. Nevertheless, the underlying molecular mechanisms of GC remain elusive. Therefor","cbCaipmxzoxBiNXm","https://ap.wps.com/l/cbCaipmxzoxBiNXm","pdf",4709209,12,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Abbreviations\n# Introduction\n# Materials and methods\n## GC sample collection","[{\"question\":\"What is the main objective of this study on CST2 in gastric cancer?\",\"answer\":\"To investigate CST2 expression and determine its molecular functions in gastric cancer, including effects on tumor behavior and drug response.\"},{\"question\":\"How was CST2 expression and its role in gastric cancer cell function assessed?\",\"answer\":\"CST2 expression was analyzed and validated by Western blot, then CST2 was overexpressed in GC cells using lentivirus, followed by assays for proliferation, colony formation, migration/invasion, cell cycle, and apoptosis.\"},{\"question\":\"What mechanism links CST2 to oxaliplatin sensitivity?\",\"answer\":\"CST2 improves chemosensitivity to oxaliplatin through the PI3K/AKT signaling pathway in gastric cancer cells.\"}]","Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway | PDF",1790029331,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4088f73dc7175e957586f8f497004bdd.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/321840f6e999d87ae86171fef9b8e537.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abcc4286f51272ca149b7c396d1b1a5b.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4078d08af2e67de68100db6c01ca7ee.webp",980,1301]